Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST
Genome & Company Revenue
Genome & Company had revenue of 11.63B KRW in the quarter ending June 30, 2024, with 213.08% growth. This brings the company's revenue in the last twelve months to 23.92B, up 59.64% year-over-year. In the year 2023, Genome & Company had annual revenue of 14.30B with 1.50% growth.
Revenue (ttm)
23.92B
Revenue Growth
+59.64%
P/S Ratio
3.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
90.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.30B | 211.39M | 1.50% |
Dec 31, 2022 | 14.08B | 13.63B | 3,021.27% |
Dec 31, 2021 | 451.25M | 300.66M | 199.67% |
Dec 31, 2020 | 150.58M | 104.75M | 228.54% |
Dec 31, 2019 | 45.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition